Nathaniel Lallatin

Title: Nathaniel Lallatin: Innovator in Monoclonal Antibody Research

Introduction

Nathaniel Lallatin is a prominent inventor based in Provo, UT (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 2 patents, Lallatin's work focuses on innovative methods for detecting and treating various diseases.

Latest Patents

Lallatin's latest patents include groundbreaking research on the anti-cancer activity of an anti-thymidine kinase monoclonal antibody. This patent discloses monoclonal antibodies to thymidine kinase 1, which are useful in methods of detecting, diagnosing, and treating cancer. Additionally, he has developed a patent for the anti-viral activity of an anti-thymidine kinase monoclonal antibody, which also focuses on methods for detecting, diagnosing, and treating viral infections.

Career Highlights

Throughout his career, Nathaniel Lallatin has worked with notable institutions, including Brigham Young University. His research has contributed to advancements in the medical field, particularly in the area of cancer and viral infections.

Collaborations

Lallatin has collaborated with Kim Leslie O'Neill, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Nathaniel Lallatin's innovative work in monoclonal antibody research has the potential to significantly improve methods for diagnosing and treating cancer and viral infections. His contributions to the field exemplify the importance of innovation in biomedical research.